4/A: Neuronetics Executive Adjusts Stock Holdings
Statement of Changes in Beneficial Ownership
Steven Pfanstiel, former EVP, CFO and Treasurer of Neuronetics, Inc., reported a minor adjustment in his beneficial ownership of common stock.
Summary
- Steven Pfanstiel, former EVP, CFO and Treasurer of Neuronetics, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's common stock.
- The filing corrects a previous report, stating that 8,569 shares of common stock were disposed of, not 16,431 as initially reported.
- These shares were sold to satisfy tax withholding obligations related to the vesting of a performance restricted stock unit award.
- The sale occurred on March 19, 2026, with the reported price of $1.34 being a weighted average of transactions ranging from $1.20 to $1.48 per share.
- Following these transactions, Pfanstiel beneficially owns 836,643 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, primarily an administrative correction of a previous report with no new strategic information or significant financial implications.
Positives
- Correction of a previous filing error, ensuring accurate reporting of stock transactions.
- The disposition of shares was for tax withholding obligations, a standard procedure upon vesting of stock awards.
Negatives
- A minor error in the initial filing required an amendment, indicating a lapse in reporting accuracy.
Risks
- The filing does not explicitly mention any new risks. However, any executive stock sale, even for tax purposes, can be perceived negatively by the market if not clearly explained.
- The weighted average sale price indicates a range of selling prices, which could imply varying market conditions during the transaction period.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a past transaction and correction.
Management Comments
- The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors regarding their stock transactions. This particular filing is an amendment to correct a previous reporting error, which is not uncommon but highlights the importance of meticulous record-keeping in regulatory filings.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| EVP, CFO and Treasurer | Steven Pfanstiel | Former |
Stakeholder Impact
- Shareholders: The correction of the filing error provides clarity on the exact number of shares disposed of by a former executive, ensuring accurate information is available.
- Management: Highlights the need for careful review of all regulatory filings to prevent errors.
Next Steps
- The reporting person has committed to providing further details on individual sale prices upon request.
Key Dates
| Date | Description |
|---|---|
| 03/19/2026 | Date of the stock transaction (disposition of shares). |
| 03/24/2026 | Date of the original Form 4 filing. |
| 05/21/2026 | Date of the signature on the amended Form 4 filing. |
Keywords
Form 4, Neuronetics, STIM, Stock Ownership, Beneficial Ownership, Insider Trading, Stock Vesting, Tax Withholding, Steven Pfanstiel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.